CA SB1072

Requires the State Department of Public Health to expand newborn screening to include 2 lysosomal storage diseases: Hurler syndrome (mucopolysaccharidosis type I) and Krabbe disease, until January 1, 2018

Exempts amendments to Genetic Disease Branch Screening Information System contracts from Public Contract Code provisions, Department of General Services approval requirements, and California Technology Agency authority over information technology projects

Maintains existing requirement that genetic disease testing program be fully supported by fees collected for newborn screening tests deposited in the Genetic Disease Testing Fund

Continues existing authority for the department to expand screening for severe combined immunodeficiency (SCID), tandem mass spectrometry disorders, and congenital adrenal hyperplasia